Johansson O, Hokfelt T, Elde RP, Schultzberg M, Terenius L (1978)
Immunohistochemical distribution of enkephalin neurons. Adv Biochem Psychopharmacol 18:51–70.
K limscha W, Tong C, Eisenach JC (1997) Intrathecal alpha(2)- adrenergic agonists stimulate acetylcholine and norepinephrine release
from the spinal cord dorsal horn in sheep: an in vivo microdialysis study.
Anesthesiology 87:110 –116.
Kuraishi Y, Hirota N, Sato Y, Kaneko S, Satoh M, Takagi H (1985)
Noradrenergic inhibition of the release of substance P from the primary
afferents in the rabbit spinal dorsal horn. Brain Res 359:177–182.
Lanier SM, Downing S, Duzic E, Homcy C J (1991) Isolation of rat
genomic clones encoding subtypes of the alpha 2-adrenergic receptor:
identification of a unique receptor subtype. J Biol Chem
266:10470 –10478.
Levine JD, Fields HL, Basbaum AI (1993) Peptides and the primary
afferent nociceptor. J Neurosci 13:2273–2286.
Millan MJ (1992) Evidence that an alpha 2A-adrenoceptor subtype me- diates antinociception in mice. Eur J Pharmacol 215:355–356.
Millan MJ, Bervoets K, Rivet JM, Widdowson P, Renouard A, Le M,
Girardon S, Gobert A (1994) Multiple alpha-2 adrenergic receptor
subtypes. II. Evidence for a role of rat R alpha-2A adrenergic receptors
in the control of nociception: motor behavior and hippocampal synthesis of noradrenaline. J Pharmacol E xp Ther 270:958 –972.
Nagy JI, Vincent SR, Staines WA, Fibiger HC, Reisine TD, Yamamura
HI (1980) Neurotoxic action of capsaicin on spinal substance P neurons. Brain Res 186:435– 444.
Nagy JI, Hunt SP, Iversen L L, Emson PC (1981) Biochemical and anatomical observations on the degeneration of peptide-containing primary afferent neurons after neonatal capsaicin. Neuroscience
6:1923–1934.
Nicholas AP, Pieribone V, Hokfelt T (1993) Distributions of mRNAs for
alpha-2 adrenergic receptor subtypes in rat brain: an in situ hybridization study. J Comp Neurol 328:575–594.
O'Halloran K D, Perl ER (1997) Effects of partial nerve injury on the
responses of c-fiber polymodal nociceptors to adrenergic agonists.
Brain Res 759:233–240.
Ono H, Mishima A, Ono S, Fukuda H, Vasko MR (1991) Inhibitory
effects of clonidine and tizanidine on release of substance P from slices
of rat spinal cord and antagonism by alpha-adrenergic receptor antagonists. Neuropharmacology 30:585–589.
Perl ER (1994) A reevaluation of mechanisms leading to
sympathetically-related pain. In: Pharmacological approaches to the
treatment of chronic pain: new concepts and critical issues (Fields H,
Liebeskind JC, eds), pp 129 –150. Seattle: IASP.
Rosin D, Z eng D, Stornetta R, Norton F, RI ley T, Okusa M, Guyenet P,
Lynch K (1993) Immunohistochemical localization of alpha-2-A ad- renergic receptors in catecholaminergic and other brainstem neurons in
the rat. Neuroscience 56:139 –155.
Rosin DL, Talley EM, Lee A, Stornetta RL, Gaylinn BD, Guyenet PG,
Lynch K R (1996) Distribution of alpha 2C -adrenergic receptor-like
immunoreactivity in the rat central nervous system. J Comp Neurol
372:135–165.
Scheinin M, L omasney JW, Hayden H D, Schambra UB, C aron MG,
Lefkowitz RJ, Fremeau RJ (1994) Distribution of alpha 2-adrenergic
receptor subtype gene expression in rat brain. Brain Res Mol Brain Res
21:133–149.
Seybold V, Elde R (1980) Immunohistochemical studies of peptidergic
neurons in the dorsal horn of the spinal cord. J Histochem C ytochem
28:367–370.
Shen K-Z, North R A, Surprenant A (1992) Potassium channels opened
by noradrenaline and other transmitters in excised membrane patches
of guinea-pig submucosal neurones. J Physiol (L ond) 445:581–599.
Stone LS, Broberger C, Wilcox GL, Ho ̈kfelt T, Elde R (1996) Characterization of alpha-2a receptor immunoreactivity in the rodent spinal
cord: relationship to noradrenergic terminals and neuropeptide content. Soc Neurosci Abstr 26:344.15.
Stone L S, K itto K F, Riedl M, Broberger C, Macmillan L, Limbird L E,
Ho ̈kfelt T, Elde R, Wilcox GL (1997a) The alpha2a-adrenergic receptor subtype in spinal adrenergic analgesia: a combined behavioral and
anatomical study. Paper presented at American Pain Society Annual
Meeting, New Orleans, November.
Stone L S, Macmillan L, K itto K F, Limbird L, Wilcox GL (1997b) The
a2a-adrenergic receptor subtype mediates spinal analgesia evoked by
a2-agonists and is necessary for spinal adrenergic /opioid synergy.
J Neurosci 17:7157–7165.
